
BusinessLead story
OpenAI acquires Orchestra Bio, folds its drug-development agents into Rosalind
The acquisition brings Orchestra's pharma-focused AI agents into OpenAI's life sciences suite, Rosalind.
Jaeden SchaferEditor in Chief3 min read
Tag · 1 story
Every story tagged Life Sciences on AI Chat Daily.

The acquisition brings Orchestra's pharma-focused AI agents into OpenAI's life sciences suite, Rosalind.
The tightly edited AI news email engineers, founders, and investors actually open. One email. Every weekday. Five minutes to finish.
The briefing read inside teams at